Daniel Faga
CIK 1673528 · President, CEO · last filed 2026-05-14
Daniel Faga is a President, CEO who has filed 35 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for TRAX, was dated May 14, 2026. Across all open-market trades the lifetime net is −$9.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $28.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$28.36M
4
35
-$9.41M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TRAX | President, CEO | 496,684 | — | — | $0 | 2 | 2026-05-14 |
| ANAB | President, CEO | 505,862 | $56.07 | $28.36M | -$6.34M | 15 | 2026-04-23 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | EVP, Chief Operating Officer | 30,638 | $58.70 | $1.80M | -$828.3K | 4 | 2021-02-03 |
| Spark Therapeutics, Inc. (ONCE) Delisted | Chief Business Officer | 0 | — | — | -$2.23M | 14 | 2019-12-17 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-14 | TRAX | Grant (A) | — | $0 | EDGAR |
| 2026-04-23 | ANAB | Disp (D) | — | $0 | EDGAR |
| 2026-04-22 | ANAB | Mixed | — | $0 | EDGAR |
| 2026-04-22 | TRAX | Grant (A) | — | $0 | EDGAR |
| 2026-03-27 | ANAB | Mixed | +16,621 | -$1.09M | EDGAR |
| 2026-01-09 | ANAB | Mixed | +12,557 | -$638.5K | EDGAR |
| 2026-01-08 | ANAB | Mixed | +8,648 | -$415.1K | EDGAR |
| 2026-01-06 | ANAB | Mixed | +19,368 | -$662.3K | EDGAR |
| 2025-01-07 | ANAB | Mixed | +33,108 | -$288.0K | EDGAR |
| 2024-07-24 | ANAB | Grant (A) | — | $0 | EDGAR |